• Nuclear Engineering and Technology
• /
• v.31 no.5
• /
• pp.498-505
• /
• 1999

Trivalent actinide-lanthanide group separation is difficult to perform on an industrial scale, because of the many drawbacks of the available chemical process. In this paper, picolinamide(C$_{8}$H$_{17}$) is synthesized and characterized, and extraction yields of Am-241, Eu-152 and Nd are determined in batch extraction experiments. In particular, the influence of the solvent is described. The extraction yields of Am-241, Eu-152 and Nd depended on the LiNO$_3$ concentration, the picolinamide(C$_{8}$H$_{17}$) concentration and the acidity. A favorable picolinamide(C$_{8}$H$_{17}$) concentration was found to be about 2M. The appropriate nitric acid concentration and LiNO$_3$ concentration were confirmed to be about 0.125M and 3M, respectively. The separation factor of Am and Eu was about 9.9 at optimum conditions. The picolinamide(C$_{8}$H$_{17}$) is a very promising extractant for the actinide(III)-lanthanides(III) separation.aration.aration.

• Proceedings of the Korean Nuclear Society Conference
• /
• 1999.05a
• /
• pp.310-311
• /
• 1999

• Journal of the Korea Convergence Society
• /
• v.8 no.1
• /
• pp.115-121
• /
• 2017

AHR is a transcription factor activated by aryl hydrocarbons, regulating the expression of XMEs (xenobiotics Metabolizing Enzymes). Even though the role of AHR in human physiology has been intensively investigated for the past decades, our understandings are still largely limited due to the deficiency of adequate chemical agents. In addition, it has been demonstrated that AHR correlates to pathogeneses for some diseases. Furthermore, emerging data suggest that the study on the AHR may provide a valid therapeutic target. Classical antagonists in current use are reported to be partial agonistic whereas a pure antagonist is demanded. In this study, o-toluidinyl ring structure of 2-methyl-4-(2-methylphenyldiazenyl)phenyl picolinamide has been modified into various structures to optimize the AHR antagonistic activity by means of convergence study of organic synthesis and molecular biology.

• Bulletin of the Korean Chemical Society
• /
• v.29 no.6
• /
• pp.1211-1216
• /
• 2008

A series of DTPA-bis(amides) functionalized by pyridine (1a-c) and N-phenylpicolinamide) (1d-e) and their Gd(III)-complexes of the type [Gd(1)($H_2O$)]·x$H_2O$ (2a-e) were prepared and characterized by analytical and spectroscopic techniques. Potentiality of 2a-e as contrast agents for magnetic resonance imaging (MRI CA) was investigated by measuring relevant physicochemical properties and relaxivities and compared with [Gd(DTPA-BMA)($H_2O$)] (DTPA-BMA=N,N''-di(methylcarbamoylmethyl)diethylenetriamine-N,N',N''-triacetate) ($Omniscan^{(R)}$). The R1 relaxivities of aqueous solutions of 2a-c are in the range of 3.33 -5.02 $mM^{-1}$$sec^{-1}$, which are comparable with those of $Omniscan^{(R)}$ (r1=4.58 $mM^{-1}sec^{-1}$). Complexes 2d-e, insoluble in water, exhibit relatively higher R1 values (8.1- 8.3 $mM^{-1}sec^{-1}$) in HP-$\beta$-CD solutions.

• Bulletin of the Korean Chemical Society
• /
• v.31 no.10
• /
• pp.2980-2984
• /
• 2010

A new poly (vinyl chloride) (PVC) membrane electrode that is highly selective to $Mn^{+2}$ ions was prepared using N,N'-bis(2'-pyridinecarboxamide)-1,2-ethane ($bpenH_2$) as a suitable neutral carrier. This concentration range ($1.0{\times}10^{-5}$ to $1.0{\times}10^{-1}\;M$) with Nernstian slope of $29.3{\pm}0.5\;mV$ per decade. The detection limit and the response time of electrode were $8.0{\times}10^{-6}\;M$ and (${\leq}15\;s$) respectively. The membrane can be used for more than two months without observing any divergence. The electrodes exhibited excellent selectivity for $Mn^{+2}$ ion over other mono-, di- and trivalent cations. Selectivity coefficients were determined by the matched potential method (MPM). The electrode can be used in the pH range from 4.0 - 9.0. The isothermal coefficient of this electrode amounted to 0.00023 V/$^{\circ}C$. The stability constant (log $K_s$) of the $Mn^{+2}$ - $bpenH_2$ complex was determined at $25^{\circ}C$ by potentiometric titration in mixed aqueous solution. The proposed electrode was applied to the determination of $Mn^{+2}$ ions in real samples.

• Korean Journal of Radiology
• /
• v.25 no.8
• /
• pp.742-748
• /
• 2024

Objective: ¹⁸F-N-(2-(Diethylamino)ethyl)-5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy) picolinamide (¹⁸F-PFPN) is a novel positron emission tomography (PET) probe designed to specifically targets melanin. This study aimed to evaluate the diagnostic feasibility of ¹⁸F-PFPN in patients with ocular or orbital melanoma. Materials and Methods: Three patients with pathologically confirmed ocular or orbital melanoma (one male, two females; age 41-59 years) were retrospectively reviewed. Each patient underwent comprehensive ¹⁸F-PFPN and ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) PET scans. The maximum standardized uptake value (SUV_max) of the lesion and the interference caused by background tissue were compared between ¹⁸F-PFPN and ¹⁸F-FDG PET imaging. In addition, the effect of intrinsic pigments in the uvea and retina on the interpretation of the results was examined. The contralateral non-tumorous eye of each patient served as a control. Results: All primary tumors (3/3) were detected using ¹⁸F-PFPN PET, while only two primary tumors were detected using ¹⁸F-FDG PET. Within each lesion, the SUV_max of ¹⁸F-PFPN was 2.6 to 8.3 times higher than that of ¹⁸F-FDG. Regarding the quality of PET imaging, the physiological uptake of ¹⁸F-FDG PET in the brain and periocular tissues limited the imaging of tumors. However, ¹⁸F-PFPN PET minimized this interference. Notably, intrinsic pigments in the uvea and retina did not cause abnormal concentrations of ¹⁸F-PFPN, as no anomalous uptake of ¹⁸F-PFPN was detected in the healthy contralateral eyes. Conclusion: Compared to ¹⁸F-FDG, ¹⁸F-PFPN demonstrated higher detection rates for ocular and orbital melanomas with minimal interference from surrounding tissues. This suggests that ¹⁸F-PFPN could be a promising clinical diagnostic tool for distinguishing malignant melanoma from benign pigmentation in ocular and orbital melanomas.